RG
Live / Registered — Registered (as of 11 Jun 2024)
What this means for you
Registered since 11 Jun 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90981041
- Registration number
- 7414310
- Mark type
- Design + words
- Filed
- 24 Aug 2021
- Published for opposition
- 23 Aug 2022
- Registered
- 11 Jun 2024
- Attorney of record
- Eric Lamb
Goods and services
- Class 005 — Pharmaceuticals: Medical, biological, pharmaceutical, and veterinary preparations containing polypeptide encoding nucleic acids for the prevention and treatment of rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders, infectious disorders and reproductive disorders;medical, biological, pharmaceutical, and veterinary preparations for medical and pharmaceutical use, namely, preparations for preventing and treating rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders, infectious disorders, and reproductive disorders; RNA-based therapeutics and therapeutic agents for in vitro preparation and in vivo, ex vivo, or on vivo delivery to cell sites; cell-based immunotherapeutic treatment by way of genetically modified cells, medicated serums for the treatment of rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders, infectious disorders and reproductive disorders; attenuated viruses and particles similar to viruses, namely, encapsulated nucleic acids for the treatment of rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders, infectious disorders and reproductive disorders; diagnostic reagents and diagnostic preparations for medical purposes; chemical reagents used for medical or veterinary purposes; biochemical reagents used for medical or veterinary purposes for the treatment of cancer, treatment of immunological diseases, and treatment of infectious diseases; adjuvants for medical purposes; macromolecules, namely, nucleic acid sequences and proteins, used for medical and veterinary purposes; a full line of pharmaceuticals, vaccines, medicines, biologics, biotherapeutics, biosimilars and therapeutics for the treatment of infectious diseases and cancer; vaccines; a full line of pharmaceuticals, medicines, biologics, biotherapeutics, biosimilars and therapeutics for the treatment of infectious diseases and cancer
Owner
- RinuaGene Biotechnology Co., Ltd., Suzhou, Jiangsu, CN
- RinuaGene Biotechnology Co., Ltd., Suzhou, Jiangsu, CN
- RinuaGene Biotechnology Co., Ltd., Suzhou, Jiangsu, CN
Prosecution history
- 11 Jun 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 11 Jun 2024 — REGISTERED-PRINCIPAL REGISTER
- 09 May 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 09 May 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 09 May 2024 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 09 May 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 May 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 12 Apr 2024 — USE AMENDMENT FILED
- 08 May 2024 — DIVISIONAL PROCESSING COMPLETE
- 12 Apr 2024 — DIVISIONAL REQUEST RECEIVED
- 08 May 2024 — SOU EXTENSION 3 GRANTED
- 12 Apr 2024 — SOU EXTENSION 3 FILED
- 23 Apr 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 12 Apr 2024 — TEAS STATEMENT OF USE RECEIVED
- 12 Apr 2024 — TEAS REQUEST TO DIVIDE RECEIVED